Sterile powder Vancomycin Hydrochloride for Injection, USP, Equivalent to 1 g in 25 ml fliptop vi...

FDA Drug Recall #D-0254-2015 — Class III — November 7, 2014

Recall Summary

Recall Number D-0254-2015
Classification Class III — Low risk
Date Initiated November 7, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hospira Inc.
Location Lake Forest, IL
Product Type Drugs
Quantity 316,640 vials

Product Description

Sterile powder Vancomycin Hydrochloride for Injection, USP, Equivalent to 1 g in 25 ml fliptop vial, 10-count tray, Rx only, Manufactured by Hospira, Inc. Lake Forest, IL 60045, NDC 0409-6533-01.

Reason for Recall

Correct Labeled Product Mispack: Product tray containing vials was mislabeled to contain another product.

Distribution Pattern

Nationwide.

Lot / Code Information

Lot# 43-240-DD; Exp. 07/16 Lot# 44-205-DD,44-455-DD,44-460-DD,44-465-DD; Exp. 08/16

Other Recalls from Hospira Inc.

Recall # Classification Product Date
D-0862-2017 Class I Infant 25% DEXTROSE Injection, USP, 2.5 g (250 ... Apr 21, 2017
D-0153-2017 Class II Fentanyl Citrate Injection, USP, 100 mcg Fentan... Nov 1, 2016
D-1500-2016 Class II DOBUTamine Injection, USP 250 mg/20 mL, 20 mL V... Aug 15, 2016
D-0169-2017 Class III 5% Lidocaine HCL and 7.5% Dextrose Injection, U... Jun 29, 2016
D-1359-2016 Class II Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL)... Jun 23, 2016

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.